Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples